KromaTiD Hires Alex D. Vodenlich as new CEO

FORT COLLINS, CO (February 3, 2014) – KromaTiD, Inc. announces that Alex D. Vodenlich of Madison, WI, will be joining as its chief executive officer. Mr. Vodenlich is an executive with over twenty years experience in the life science industry. He is the former President and CEO of Gentel Biosciences, Inc., a provider of multiplex immunoassay technologies. Read more